Source:http://linkedlifedata.com/resource/pubmed/id/16387288
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-1-23
|
pubmed:abstractText |
Tumor-promoting activity caused by the short-term administration of p-hydroxybenzenediazonium (PDQ) has been assayed in rats fed on a Mg-deficient diet as a reference model versus rats fed on a standard diet as controls. For 5 weeks groups of 20 rats, fed either on the Mg-deficient or standard diet, were treated simultaneously with PDQ. A group of 10 Mg-deficient rats remained untreated. Topical application of PDQ was followed by the appearance of macroscopic alterations in the skin, which were more evident in the Mg-deficient rats. No deaths occurred during the treatment. After 5 weeks' PDQ treatment the rats were killed and histological analyses were made. Tissues from the skin, liver, heart, kidney, lung and thymus were screened by conventional staining methods. Both the PDQ-treated Mg-deficient and PDQ-treated control rats presented tissue lesions, although to a different extent. The untreated Mg-deficient rats showed no such lesions. Mg-deficient rats treated with PDQ developed significant incipient fibrosarcomas (p<0.05) and extended hyperplasia (p<0.001), particularly in the skin, accompanied by a significant increase in the thickness of collagen (mean value: 445.4+/-47.2microm, p<0.05) compared to the control PDQ-treated group (mean values: 258.7+/-36.4microm). The overall results provide objective proof of tumor-promoting activity after 5 weeks' treatment with PDQ. Such a fast response is interpreted as being linked to the increased vulnerability of the membrane caused by Mg deficiency, which would more readily facilitate the toxic activity of p-hydroxybenzenediazonium ions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-2797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
186-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16387288-Animals,
pubmed-meshheading:16387288-Body Weight,
pubmed-meshheading:16387288-Diazonium Compounds,
pubmed-meshheading:16387288-Magnesium Deficiency,
pubmed-meshheading:16387288-Male,
pubmed-meshheading:16387288-Neoplasms,
pubmed-meshheading:16387288-Rats,
pubmed-meshheading:16387288-Rats, Wistar,
pubmed-meshheading:16387288-Spectrum Analysis
|
pubmed:year |
2006
|
pubmed:articleTitle |
Tumor-promoting activity of p-hydroxybenzenediazonium is accelerated in Mg-deficient rats.
|
pubmed:affiliation |
Department of Physical Chemistry, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain. bqosso@ugr.es
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|